Injectable therapeutic compositions

Details Injectable therapeutic compositions Injectable therapeutic compositions

1976-04-16

1978-05-16

Robinson, Allen J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

424251, A61K 31505, A61K 31625

Patent

active

040899497

ABSTRACT:
An injectable synergistic one-phase formulation, which comprises a potentiated composition consisting of sulphadimidine, sulphathiazole and trimethoprim dissolved in aqueous N,N-dimethylacetamide, wherein the X% w/v concentration is from 10 to 50% w/v, the ratio of sulphadimidine to sulphathiazole is from 0.3 to 3, the ratio of the sulphonamides together to trimethoprim from 3.5 to 7, and the water content of the N,N-dimethylacetamide is less than (50-X)% v/v, methods for the preparation of such a formulation and for the use of the same for the treatment of animals.

REFERENCES:
patent: 2895874 (1959-07-01), Lux et al.
patent: 3507952 (1970-04-01), Rednick et al.
patent: 3551564 (1970-12-01), Klaui et al.
patent: 3985873 (1976-10-01), Alvan et al.
patent: 3985876 (1976-10-01), Hazlett et al.

Affiliated with

Also associated with

Rating

Injectable therapeutic compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Injectable therapeutic compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable therapeutic compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1197749